Sanofi-Aventis Financial Statements
Sanofi-Aventis Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Sanofi-Aventis Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 43,019.0 | 38,934.3 | 33,770.8 |
| Gross Profit ($ mil.) | 31,867.7 | 28,921.2 | 24,808.5 |
| Operating Income ($ mil.) | 8,706.3 | 5,649.6 | 4,229.5 |
| Total Net Income ($ mil.) | 8,369.0 | 5,326.1 | 2,608.1 |
| Diluted EPS (Net Income) | 3.89 | 3.92 | 1.94 |
Sanofi-Aventis Stock Quote & Chart
| 07/24/08 08:46:50 EST •
NYSE •
36.26
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Sanofi-Aventis Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.19 | 3.81 | 1.53 |
| Price/Earnings Ratio | 9.23 | 16.07 | 15.12 |
| Price/Book Ratio | 0.12 | 2.80 | 1.46 |
| Price/Cash Flow Ratio | 0.78 | 11.72 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Sanofi-Aventis Financial Ratios
Sanofi-Aventis Competitive Intelligence
| Eli Lilly | Merck | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 24,197.7 | 48,418.0 |
| Employees | 40,600 | 59,800 | 86,600 |
| Market Cap ($ mil.) | 54,199.6 | 78,520.0 | 123,532.5 |
Competitive Landscape




